Scope and frequency of fluconazole trailing assessed using EUCAST in invasiveCandidaspp. isolates

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Multilocus microsatellite markers for molecular typing of Candida tropicalis isolates

(2014) Yuan Wu et al.   BMC MICROBIOLOGY

Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth

(2013) Marcos Dornelas-Ribeiro et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

(2012) Maiken C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure

(2008) T. Coenye et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

(2008) J.L. Rodriguez-Tudela et al.   CLINICAL MICROBIOLOGY AND INFECTION